The Cost Effectiveness of Bisphosphonates for the Prevention and Treatment of Osteoporosis: A Structured Review of the Literature

Author： Fleurence Rachael L.

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.25, Iss.11, 2007-01, pp. : 913-933

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Alendronate (Fosamax ® ) for the Treatment of Osteoporosis and Prevention of Fractures

By Johnell O.

PharmacoEconomics, Vol. 21, Iss. 5, 2003-01 ,pp. : 305-314

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Multi-Therapy Treatment Strategies in the Prevention of Vertebral Fractures in Postmenopausal Women with Osteoporosis

By Rosner A.J.

PharmacoEconomics, Vol. 14, Iss. 5, 1998-11 ,pp. : 559-573

Adis International

Access to resources Recommend Favorite

Safety Considerations with Bisphosphonates for the Treatment of Osteoporosis

By Strampel William

Drug Safety, Vol. 30, Iss. 9, 2007-01 ,pp. : 755-763

Adis International

Access to resources Recommend Favorite

Cost–Effectiveness of Osteoporosis Screening Followed by Treatment: The Impact of Medication Adherence

By Hiligsmann Mickaël Gathon Henry-Jean Bruyère Olivier Ethgen Olivier Rabenda Véronique Reginster Jean-Yves

Value in Health, Vol. 13, Iss. 4, 2010-06 ,pp. : 394-401

Blackwell Publishing

Access to resources Recommend Favorite

Cost Effectiveness of Ibandronate for the Prevention of Fractures in Inflammatory Bowel Disease-Related Osteoporosis: Cost-Utility Analysis Using a Markov Model

By Kreck Simon Klaus Jochen

PharmacoEconomics, Vol. 26, Iss. 4, 2008-01 ,pp. : 311-328

Adis International

Access to resources Recommend Favorite